Found: 6
Select item for more details and to access through your institution.
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1190, doi. 10.3390/cancers11081190
- By:
- Publication type:
- Article
A randomised trial of [<sup>18</sup>F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol.
- Published in:
- BJUI Compass, 2023, v. 4, n. 5, p. 513, doi. 10.1002/bco2.243
- By:
- Publication type:
- Article
Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1021, doi. 10.3390/diagnostics10121021
- By:
- Publication type:
- Article
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1001, doi. 10.3390/diagnostics10121001
- By:
- Publication type:
- Article
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1510, doi. 10.1007/s00259-023-06108-4
- By:
- Publication type:
- Article
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 5, p. 1164, doi. 10.1007/s00259-018-4248-0
- By:
- Publication type:
- Article